GoodRx Holdings, Inc.

GDRX Healthcare Health Information Services

GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.

3.36 0.15 −4.27%
Market cap
$1.2B
P/E
62.7×
Fwd P/E
30.9×
Dividend yield
—
F-score
6/9
Altman Z
0.44
Beneish M
−2.40
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

45.39 30.04 30.82 53.73
P/S ratio
1.83 1.21 0.85 1.24
P/FCF ratio
13.98 10.29 6.91 7.42
P/Operating CF
19.30 29.36 56.38 12.09
P/B ratio
2.44 1.57 1.07 1.51
Price to Tangible BV
12.62 7.92 5.12 6.14
EV/Sales
2.10 1.50 1.17 1.49
EV/EBITDA
10.14 6.83 5.54 7.06
EV/Operating CF
9.36 7.10 5.40 5.79
EV/FCF
16.03 12.70 9.52 8.87
Quick Ratio
2.62 2.02 0.55 0.41
Current Ratio
3.11 2.61 1.47 1.38
Net Debt/EBITDA
5.91 4.89 6.94 4.11
Debt/Assets
36.90% 34.78% 24.11% 20.77%
Debt/Equity
0.81 0.79 0.78 0.75
Asset Turnover
0.60 0.57 0.48 0.43
Operating CF/Net income
67.94 6.06 10.13 9.47
Capex/Depreciation
(0.82) (0.67) (0.97) (0.63)
Interest Coverage
1.35 2.18 1.43 2.41
Research and Development Expense of Revenue
15.82% 14.86% 15.55% 13.33%
Selling, General and Administrative Expense of Revenue
58.94% 52.65% 55.60% 53.29%
Intangible Assets out of Total Assets
0.37 0.35 0.24 0.21
Share Based Compensation of Revenue
9.24% 9.20% 8.51% 8.28%
Graham Net Nets
(0.11) (0.15) (0.20) (0.10)
Graham Number
1.91 1.87 1.62 1.52
Earnings Yield
2.20% 3.33% 3.24% 1.86%
Free Cash Flow Yield
7.15% 9.72% 14.46% 13.48%
Revenue per Share
0.57 0.55 0.57 0.59
Operating CF per Share
0.22 0.09 0.03 0.24
Capex per Share
(0.05) (0.04) (0.06) (0.04)
Free Cash Flow per Share
0.17 0.05 (0.03) 0.20
Cash per Share
0.79 0.73 0.69 0.87
Shareholders Equity per Share
1.73 1.73 1.83 1.91
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.73 1.73 1.83 1.91
Free Cash Flow
58.02 17.06 (9.81) 66.42
Working Capital
383.66 397.10 407.27 441.46
Capital Expenditures
(18.00) (15.83) (21.64) (14.41)
Net Current Asset Value
(159.28) (144.69) (132.80) (96.00)
EV/EBIT
20.27 13.63 11.77 15.58
Capex to Sales
0.09 0.08 0.11 0.07
Price to Operating Income
17.68 11.04 8.54 13.04
Other line items
Average Receivables
167.27 190.84 196.42 185.58
Average Payables
20.56 16.77 14.89 17.16
Average Assets
1,340.18 1,396.06 1,658.26 1,830.82
Average Common Equity
648.57 670.46 638.17 645.32

Fold the line items

Columns are period end dates